[19] What Could Change Coverage State-Level Changes to Watch California (CalPERS): Transitioned from OptumRx to CVS Caremark on January 1, 2026state employees should verify new formulary status [23] Indiana: State employee plans now exclude all GLP-1s for weight loss (not just Zepbound) effective January 1, 2026 [24] Wyoming: Launched new CVS Caremark weight management program with GLP-1 access via enrollment (January 2026) [25] For Medicare policy updates, see our Medicare guide
Quick Links GLP2 + Cagrilintide Blend Peptide The Four-Pathway Metabolic Research Compound Also known as: GLP3/Cagri Blend, Lean Blend, CagriGLP3 Why Researchers Choose GLP3 + Cagrilintide Blend Peptide Unlike single or dual-pathway peptides, this blend targets four distinct metabolic receptorscombining GLP3s triple incretin action (GLP-1, GIP, and glucagon receptors) with Cagrilintides amylin pathway activation
People who take semaglutide or tirzepatide should talk to their physicians if they are concerned about ongoing access to the medications that they need, rather than turning to a product that might not be safe
In PTSD mice models, trauma exposure increased tyrosine hydroxylase expression (the rate-limiting enzyme in catecholamine biosynthesis), elevating stress hormones epinephrine and norepinephrine in serum and colon, which upregulated claudin-2 expression, confirming gut barrier dysfunction (Yadav et al., 2023)
This individualized approach helps ensure that the dosage is both practical and safe
Coverage for GLP-1 obesity indications varies plan-by-plan and employer-by-employer, even within the same insurance company